梗阻性肥厚型心肌病的治疗进展  

Advances in Treatment of Hypertrophic Obstructive Cardiomyopathy

作　　者：黄恺悦 许勇[1] HUANG Kaiyue;XU Yong(Department of Cardiology,The Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072,Sichuan,China)

机构地区：[1]成都中医药大学附属医院心内科,四川成都610072

出　　处：《心血管病学进展》2018年第4期663-667,共5页Advances in Cardiovascular Diseases

基　　金：国家自然科学基金青年基金项目(81603615)

摘　　要：肥厚型心肌病是指并非完全因心脏负荷异常引起的左心室室壁增厚,是常见的常染色体显性遗传病。梗阻性肥厚型心肌病患者临床症状重,恶性心律失常和心脏性猝死风险高,现就此疾病近年的治疗进展做一综述。Hypertrophic cardiomyopathy refers to the hypertrophy of the left ventricular wall, which is not entirely due to abnormal cardiac load. It is a common autosomal dominant genetic disease. Patients with hypertrophic obstructive eardiomyopathy have severe clinical symptoms, high risk of malignant arrhythmia and sudden cardiac death. In this paper we review the recent research progress in treatment of hypertrophic obstructive cardiomyopathy.

关 键 词：肥厚型心肌病 梗阻性肥厚型心肌病 射频导管消融术 

分 类 号：R542.2[医药卫生—心血管疾病]